
201 - 500 funcionários
Fundada em 2003
🏥 Saúde
💼 Consultoria
📣 Marketing
🔥 Investimento no último ano
💰 $500.000.000 Post-IPO Equity - Summit Therapeutics em 2025-10
Healthcare • Consulting • Marketing
A Summit Therapeutics, Inc. é uma empresa biofarmacêutica especializada em oncologia, focada na descoberta, desenvolvimento e comercialização de novas terapias medicinais para melhorar a qualidade e a duração de vida de pacientes com necessidades médicas não atendidas. A empresa está avançando com o ivonescimab (SMT112), um novo anticorpo biespecífico que tem como alvo PD-1 e VEGF, através de múltiplos ensaios clínicos de Fase 3 para o câncer de pulmão de não pequenas células e outros tumores sólidos sob licença da Akeso. A Summit enfatiza o desenvolvimento clínico, estratégias de registro regulatório e potencial comercialização em seus territórios licenciados enquanto promove opções de tratamento que beneficiam tanto pacientes quanto cuidadores.
🕒 Agosto 25
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $190.000 - $237.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
👻 Score fantasma 5%
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

201 - 500 funcionários
Fundada em 2003
🏥 Saúde
💼 Consultoria
📣 Marketing
🔥 Investimento no último ano
💰 $500.000.000 Post-IPO Equity - Summit Therapeutics em 2025-10
Healthcare • Consulting • Marketing
A Summit Therapeutics, Inc. é uma empresa biofarmacêutica especializada em oncologia, focada na descoberta, desenvolvimento e comercialização de novas terapias medicinais para melhorar a qualidade e a duração de vida de pacientes com necessidades médicas não atendidas. A empresa está avançando com o ivonescimab (SMT112), um novo anticorpo biespecífico que tem como alvo PD-1 e VEGF, através de múltiplos ensaios clínicos de Fase 3 para o câncer de pulmão de não pequenas células e outros tumores sólidos sob licença da Akeso. A Summit enfatiza o desenvolvimento clínico, estratégias de registro regulatório e potencial comercialização em seus territórios licenciados enquanto promove opções de tratamento que beneficiam tanto pacientes quanto cuidadores.
• Interface with US population-based decision makers, including payers, health systems, clinical pathway organizations, P&T committees, and policy makers • Educate key stakeholders on the clinical, economic, and humanistic impact of ivonescimab • Inform formulary access, pathway/guideline decisions, and improve cancer patient outcomes • Provide objective, scientifically sound medical information using economic models, outcomes tools, educational programs, and collaborations • Partner compliantly with the commercial market access field team to facilitate access to ivonescimab • Independently cultivate and manage relationships with population-based decision makers • Collaborate with HEOR and market access teams on scientific engagement strategy • Provide clinical and healthcare economic information to payers and formulary decision-makers • Communicate clinical and economic information related to ivonescimab proactively and reactively • Capture and communicate stakeholder insights, evidence gaps, and collaboration opportunities internally • Contribute to content strategy development and execute aligned field tactics • Support inclusion of ivonescimab in clinical/payer pathways and treatment order sets while optimizing budget assessments • Collaborate with medical affairs, HEOR, market access, and other colleagues on account engagement plans • Present clinical, humanistic, and economic evidence and value propositions to payer audiences • Monitor market and payer needs and provide actionable recommendations for medical and market access strategy • Perform other assigned duties
• MD, PharmD, or PhD in Health Services Research, Health Economics, or related field • Minimum of 12+ years relevant experience in the healthcare industry • Minimum of 5+ years direct experience in pharmaceutical, managed care, or consulting industries • Previous experience in Oncology, preferably non-small cell lung cancer (NSCLC) • Previous experience in a field-based role • Strong understanding of the US healthcare system, market access landscape, and value-based decision makers • Experience analyzing healthcare data and utilizing real-world evidence (RWE) is a plus • Strong analytical capabilities • Excellent communication skills, including ability to communicate large amounts of scientific information clearly, concisely, and memorably • Ability to work collaboratively across diverse teams and manage multiple stakeholders • Ability to influence and collaborate to make a business impact • Ability to be proactive, enthusiastic, and goal oriented • Willingness to travel up to approximately 75% of the time, including overnight travel for internal and external meetings
• Bonus may be included in the total compensation package • Stock may be included in the total compensation package • Benefits may be included in the total compensation package • Other applicable variable compensation may be included • Equal opportunity employer committed to a diverse environment
Candidatar-se🕒 Agosto 25
IQVIA executive leading strategic clinical partnerships for mid-sized pharma customers. Driving global delivery, governance, financial performance, and customer growth across healthcare services.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $165.400 - $460.800 / ano
💰 $1.000.000.000 Post-IPO Debt em 2023-05
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 25
Strategic services director leading North American Rail Solutions’ rail operations, growth strategies, compliance, and profitability. Managing teams, processes, customer relationships, and performance improvement.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 25
Director leading end-to-end product development for StarTech.com’s global tech connectivity portfolio. Improving NPI execution, quality, compliance, time-to-market, and operational efficiency.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 24
Strategic accounts director retaining and expanding large employer healthcare accounts for Garner Health. Advising clients on benefits strategy, plan performance, and healthcare cost reduction.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Agosto 24
Director Quality leading quality programs for Blattner’s utility-scale gas power construction projects. Driving quality assurance, KPI management, corrective actions, and team development across EPC operations.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $178.151 - $258.319 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório